Home » Topics » Regulatory » Patents

Patents
RSS

Novel radiosensitizers claimed by K. Marcinkowski University of Medical Sciences

July 8, 2009

Novel guanylate cyclase activators emerge from GlaxoSmithKline R&D

July 8, 2009

Bar-Ilan University patent describes novel P2Y1 receptor agonists

July 7, 2009

Cellzome presents PI3Kgamma inhibitors for the treatment of immunological disorders

July 7, 2009

Action Pharma discovers and patents novel melanocortin receptor ligands

July 7, 2009

Wyeth discovers novel PDE10 inhibitors for the treatment of psychosis, mood disorders, etc.

July 6, 2009

Novel histamine H3 receptor ligands revealed in recent Janssen patents

July 6, 2009

Merck Frosst describes cysteine protease inhibitors for the treatment of parasitic infections

July 6, 2009

Bristol-Myers Squibb discovers new NS5B polymerase inhibitors for the treatment of HCV

July 3, 2009

Vasopressin V1b receptor ligands under development at Abbott

July 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...